The
<font> ETF Innovators Health IT Index </font> has been a strong performer over the past month, with many of the index components outpacing both the 12.7% gain in the S&P 500 ETF (NYSE:SPY) and the 6.5% gain in the Healthcare Sector SPDR (NYSE:XLV) during that period. The following are some top performing stocks from the index over the past month: Allscripts-Misys (NASDAQ:MDRX) up 15.8%, Cerner (NASDAQ:CERN) up 33.2%, Eclipsys (NASDAQ:ECLP) up 64.9%, athenahealth (NASDAQ:ATHN) up 33.1%, and Merge Healthcare (NASDAQ:MRGE) up 39.4%.
A recent addition to the Health IT Index is A.D.A.M. Inc. (Nasdaq:ADAM), which is up 16.1% in the past month. ADAM provides health information and tehcnology solutions for a wide variety of audiences, including consumers, employers, health benefit organizations, and educational institutions. The Company's products and services enable consumers to play an active role in their health and help to reduce healthcare costs for employers (
<font> Benergy System </font> ) and health benefit managers.
In early May, the Company announced the introduction of a new swine flu topic to its online
<font> Multimedia Encyclopedia </font> , which includes over 3,900 unique articles covering a wide variety of health topics that can be integrated into third-party websites. In late April, ADAM announced the availability of Medzio as a free mobile health application for Apple's (NASDAQ:AAPL) iPhone. The initial features include (1) first aid information, (2) interactive health information topics, (3) a search feature for local medical facilities, healthcare providers, and pharmacies, and (4) a mobile health network with information on healthcare pricing.
ADAM will conduct its
<font> 1Q09 earnings conference call </font> on Tuesday 5/12/09 at 10am (ET) with results released before the market open on the same day. The
<font> lone analyst estimate </font> for the Company expects 1Q09 revenue of $7.1M and EPS of $0.09 with a full-year estimate of $28.9M for revenue and $0.36 for EPS. As of the market close on 5/8/09, ADAM has a market cap of about $33M and is trading at $3.31 per share.
Disclosure: No positions.
